Features of the metabolic syndrome in the Berlin fat mouse as a model for human obesity

Obesity Facts

Volumn 4, Issue 4, 2011, Pages 270-277

  Hantschel, Claudia ^a   Wagener, Asja ^a   Neuschl, Christina ^a   Teupser, Daniel ^b   Brockmann, Gudrun A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Adipokines; Glucose clearance; Incretins; Insulin tolerance; Lipoproteins; Obesity

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BERLIN FAT MOUSE BFMI860; BODY FAT; CLEARANCE; DYSLIPIDEMIA; EXPERIMENTAL MOUSE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HYPERLEPTINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; LIPID ANALYSIS; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DIETARY FATS; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; MICE; MICE, OBESE; OBESITY; TRIGLYCERIDES;

EID: 80053075816     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000330819     Document Type: Article

References (45)

1. Grundy SM: Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 2006;83:1248-1251. (Pubitemid 44713050)
2. American Heart Association; National Heart, Lung, and Blood Institute; Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Executive summary. Cardiol Rev 2005;13:322-327. (Pubitemid 41579599)
3. Grundy SM: Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 2006;5:295-309.
4. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 2000;106:473-481. (Pubitemid 30666380)
5. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006;444:881-887. (Pubitemid 46024995)
6. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
7. Eckel RH, Alberti KGMM, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2010;375:181-183.
8. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
9. McFarlane Samy I, Banerji Maryann, Sowers James R: Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-718.
10. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556. (Pubitemid 38766330)
11. Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783. (Pubitemid 44453463)
12. Flier JS: Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 1998;83:1407-1413. (Pubitemid 28500994)
13. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770. (Pubitemid 28485436)
14. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439-451. (Pubitemid 40686653)
15. Attie AD, Scherer PE: Adipocyte metabolism and obesity. J Lipid Res 2009;50(suppl):S395-S399.
16. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995;1:1311-1314.
17. Caprio S, Tamborlane WV, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, Sherwin RS: Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol Endocrinol Metab 1996;271:E626-E630.
18. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
19. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935. (Pubitemid 32472900)
20. Taft RA, Davisson M, Wiles MV: Know thy mouse. Trends Genet 2006;22:649-653. (Pubitemid 44738127)
21. Nguyen D, Xu T: The expanding role of mouse genetics for understanding human biology and disease. Dis Model Mech 2008;1:56-66.
22. Wagener A, Schmitt AO, Aksu S, Schlote W, Neuschl C, Brockmann GA: Genetic, sex, and diet effects on body weight and obesity in the Berlin Fat Mouse Inbred lines. Physiol Genom 2006;27:264-270. (Pubitemid 46708778)
23. Flurkey K, Currer JM, Harrison DE: Mouse models in aging research; in Fox JG, Barthold SW, Davisson MT, Newcomer CE, Quimby FW, Smith AL (eds): The Mouse in Biomedical Research. Burlington, American College of Laboratory Animal Medicine Series, 2007, pp 637-672.
24. Neuschl C, Hantschel C, Wagener A, Schmitt AO, Illig T, Brockmann GA: A unique genetic defect on chromosome 3 is responsible for juvenile obesity in the Berlin Fat Mouse. Int J Obes 2010;34:1706-1714.
25. Meyer CW, Wagener A, Rink N, Hantschel C, Heldmaier G, Klingenspor M, Brockmann GA: High energy digestion efficiency and altered lipid metabolism contribute to obesity in BFMI mice. Obesity 2009;17:1988-1993.
26. Clee SM, Attie AD: The genetic landscape of type 2 diabetes in mice. Endocr Rev 2007;28:48-83. (Pubitemid 46220850)
27. Mekada K, Abe K, Murakami A, Nakamura S, Nakata H, Moriwaki K, Obata Y, Yoshiki A: Genetic differences among C57BL/6 substrains. Exp Anim 2009;58:141-149.
28. Taicher GZ, Tinsley FC, Reiderman A, Heiman ML: Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 2003;377:990-1002. (Pubitemid 40877830)
29. Tinsley FC, Taicher GZ, Heiman ML: Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obesity 2004;12:150-160. (Pubitemid 41137499)
30. Teupser D, Tan M, Persky AD, Breslow JL: Atherosclerosis quantitative trait loci are sex-and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/-mice. Proc Natl Acad Sci U S A 2006;103:123-128. (Pubitemid 43076115)
31. Buchmann J, Meyer C, Neschen S, Augustin R, Schmolz K, Kluge R, Al-Hasani H, Jurgens H, Eulenberg K, Wehr R, Dohrmann C, Joost HG, Schurmann A: Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesity. Endocrinology 2007;148:1561-1573. (Pubitemid 46457102)
32. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495. (Pubitemid 38680001)
33. Lee S, Muniyappa R, Yan X, Chen H, Yue LQ, Hong EG, Kim JK, Quon MJ: Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. Am J Physiol Endocrinol Metab 2008;294:E261-E270. (Pubitemid 351231452)
34. R Development Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2011, ISBN 3-900051-07-0. www. R-project.org.
35. Elrick H, Stimmler L, Hlad CJ Jr, Arai Y: Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 1964;24:1076-1082.
36. Drucker DJ, Nauck MA: The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-1705. (Pubitemid 46048557)
37. Kónya A, Wright KC, Gounis M, Kandarpa K: Animal models for artherosclerosis, restenosis, and endovascular aneurysm repair; in Conn PM (ed): Sourcebook of Models for Biomedical Research. Totowa, Humana Press, 2008, pp 369-384.
38. Benoit SC, Clegg DJ, Seeley RJ, Woods SC: Insulin and leptin as adiposity signals. Recent Prog Horm Res 2004;59:267-285. (Pubitemid 41327155)
39. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB: Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006;8:264-280.
40. Goldfine AB, Kahn CR: Adiponectin: Linking the fat cell to insulin sensitivity. Lancet 2003;362:1431-1432. (Pubitemid 37352876)
41. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH: A two-step model for development of non-insulin-dependent diabetes. Am J Med 1991;90:229-235.
42. Karelis AD: Metabolically healthy but obese individuals. Lancet 2008;372:1281-1283.
43. Bielschowsky M, Bielschowsky F: A new strain of mice with hereditary obesity. Proc Univ Otago Med School 1953;31:29-31.
44. Nakamura M, Yamada K: Studies on a diabetic (KK) strain of the mouse. Diabetologia 1967;3:212-221.
45. Allan MF, Eisen EJ, Pomp D: The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity. Obes Res 2004;12:1397-1407. (Pubitemid 41137446)